How does stem cell therapy help children with autism?

MSC therapy reduces neuroinflammation, modulates the immune system, and promotes neural connectivity. Over 500 children treated at our clinic, with 75% showing improvements in communication, social interaction, eye contact, and behavioral patterns.

At what age can a child receive stem cell therapy for autism?

Children as young as 2 years old can receive MSC therapy for autism. Earlier intervention typically yields better outcomes. Our medical team evaluates each child individually to determine the optimal treatment protocol.

How many sessions of stem cell therapy are needed for autism?

Most children undergo 1-2 initial sessions, with follow-up sessions recommended every 6-12 months. Each session includes IV infusion and/or intrathecal administration of 30-100 million MSCs depending on age and weight.

What improvements can be expected after stem cell therapy for autism?

Parents commonly report improvements in eye contact, speech development, social interaction, attention span, reduced repetitive behaviors, better sleep patterns, and improved digestive function within 1-6 months after treatment.

Is stem cell therapy for autism safe for children?

Yes. Our Wharton's jelly MSCs are immunologically privileged and well-tolerated in pediatric patients. We have treated over 500 children with an excellent safety profile and no serious adverse events reported.

Autism Stem Cell Therapy Abroad: A Guide for Families in the Netherlands & UAE

A coordination guide for families in the Netherlands and the UAE exploring stem cell therapy for autism abroad. Regulatory context at home, travel logistics to Istanbul, costs, and how care is coordinated with your local behavioural and developmental team. StemCell Longevita is an international patient coordination platform, not a treatment provider.

Why Dutch and UAE Families Look Abroad for Autism Treatment

Families raising a child on the autism spectrum in the Netherlands and the United Arab Emirates share a common experience: strong local support for behavioural and developmental therapy, but no locally approved cell-based biological intervention. Dutch care is anchored in evidence-based behavioural approaches, speech and language therapy, and multidisciplinary support coordinated through the GGZ system and paediatric centres. In Dubai and Abu Dhabi, families access a growing network of private developmental clinics, ABA providers, and special-education programmes. Neither system offers mesenchymal stem cell (MSC) therapy as a routine, reimbursed pathway, which leads some well-informed parents to research treatment abroad.

StemCell Longevita's Role: Coordination, Not Treatment

StemCell Longevita is an international patient coordination platform based in Istanbul, Turkey. We are not a treatment provider, we do not diagnose autism, and we do not promise a cure. Our role is to give families honest, evidence-grounded information, assess whether a child may be a reasonable candidate, and coordinate access to GMP-standard care at an accredited partner hospital — while keeping the home care team informed. MSC therapy does not change a child's fundamental neurology; it is studied as a supportive, adjunctive option relating to inflammation-related symptoms in a subset of children, with outcomes that vary widely between individuals.

Regulation, Travel and Cost for the Netherlands and UAE

In the Netherlands, MSC therapy for autism is not approved or reimbursed under EU/EMA rules; in the UAE it is not an approved indication despite the country's investment in regenerative medicine research. Istanbul is roughly 3.5 hours from Amsterdam and 4.5 hours from Dubai or Abu Dhabi, with English and Dutch consultation and Arabic-speaking coordination support. A typical stay is 4–6 days, planned around a child's sensory and routine needs and, where possible, school holidays. Coordinated treatment is typically 60–80% less than comparable private clinics in Western Europe, quoted individually only after a medical review. Throughout, families should continue ABA, speech, and developmental therapy at home — MSC therapy complements this programme, it never replaces it.

Frequently Asked Questions

How does stem cell therapy help children with autism?: MSC therapy reduces neuroinflammation, modulates the immune system, and promotes neural connectivity. Over 500 children treated at our clinic, with 75% showing improvements in communication, social interaction, eye contact, and behavioral patterns.
At what age can a child receive stem cell therapy for autism?: Children as young as 2 years old can receive MSC therapy for autism. Earlier intervention typically yields better outcomes. Our medical team evaluates each child individually to determine the optimal treatment protocol.
How many sessions of stem cell therapy are needed for autism?: Most children undergo 1-2 initial sessions, with follow-up sessions recommended every 6-12 months. Each session includes IV infusion and/or intrathecal administration of 30-100 million MSCs depending on age and weight.
What improvements can be expected after stem cell therapy for autism?: Parents commonly report improvements in eye contact, speech development, social interaction, attention span, reduced repetitive behaviors, better sleep patterns, and improved digestive function within 1-6 months after treatment.
Is stem cell therapy for autism safe for children?: Yes. Our Wharton's jelly MSCs are immunologically privileged and well-tolerated in pediatric patients. We have treated over 500 children with an excellent safety profile and no serious adverse events reported.

Autism Stem Cell Therapy Abroad: A Guide for Families in the Netherlands & UAE

Why Dutch and UAE Families Look Abroad for Autism Treatment

StemCell Longevita's Role: Coordination, Not Treatment

Regulation, Travel and Cost for the Netherlands and UAE

Frequently Asked Questions

Transform Your Health with Regenerative Medicine in Istanbul